213 related articles for article (PubMed ID: 11434720)
1. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics.
Appleman LJ; Tzachanis D; Grader-Beck T; van Puijenbroek AA; Boussiotis VA
J Mol Med (Berl); 2001; 78(12):673-83. PubMed ID: 11434720
[TBL] [Abstract][Full Text] [Related]
2. The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors.
Jackson SK; DeLoose A; Gilbert KM
Immunology; 2002 Aug; 106(4):486-95. PubMed ID: 12153511
[TBL] [Abstract][Full Text] [Related]
3. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes.
Boussiotis VA; Freeman GJ; Taylor PA; Berezovskaya A; Grass I; Blazar BR; Nadler LM
Nat Med; 2000 Mar; 6(3):290-7. PubMed ID: 10700231
[TBL] [Abstract][Full Text] [Related]
4. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.
Appleman LJ; Berezovskaya A; Grass I; Boussiotis VA
J Immunol; 2000 Jan; 164(1):144-51. PubMed ID: 10605005
[TBL] [Abstract][Full Text] [Related]
5. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy.
Verdoodt B; Blazek T; Rauch P; Schuler G; Steinkasserer A; Lutz MB; Funk JO
Eur J Immunol; 2003 Nov; 33(11):3154-63. PubMed ID: 14579284
[TBL] [Abstract][Full Text] [Related]
6. Induction of immunologic tolerance for allogeneic hematopoietic cell transplantation.
Appleman LJ; Tzachanis D; Grader-Beck T; Van Puijenbroek AA; Boussiotis VA
Leuk Lymphoma; 2002 Jun; 43(6):1159-67. PubMed ID: 12152983
[TBL] [Abstract][Full Text] [Related]
7. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
Wells AD; Walsh MC; Bluestone JA; Turka LA
J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
[TBL] [Abstract][Full Text] [Related]
8. Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease.
Boussiotis VA; Chen ZM; Zeller JC; Murphy WJ; Berezovskaya A; Narula S; Roncarolo MG; Blazar BR
Blood; 2001 Jan; 97(2):565-71. PubMed ID: 11154238
[TBL] [Abstract][Full Text] [Related]
9. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1.
Kubsch S; Graulich E; Knop J; Steinbrink K
Eur J Immunol; 2003 Jul; 33(7):1988-97. PubMed ID: 12884865
[TBL] [Abstract][Full Text] [Related]
10. T cell effector function and anergy avoidance are quantitatively linked to cell division.
Wells AD; Walsh MC; Sankaran D; Turka LA
J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
Powell JD; Lerner CG; Schwartz RH
J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
[TBL] [Abstract][Full Text] [Related]
12. T cell hyporesponsiveness induced by oral administration of ovalbumin is associated with impaired NFAT nuclear translocation and p27kip1 degradation.
Asai K; Hachimura S; Kimura M; Toraya T; Yamashita M; Nakayama T; Kaminogawa S
J Immunol; 2002 Nov; 169(9):4723-31. PubMed ID: 12391180
[TBL] [Abstract][Full Text] [Related]
13. TCR engagement in the absence of cell cycle progression leads to T cell anergy independent of p27(Kip1).
Powell JD; Bruniquel D; Schwartz RH
Eur J Immunol; 2001 Dec; 31(12):3737-46. PubMed ID: 11745394
[TBL] [Abstract][Full Text] [Related]
14. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
15. Induction of anergy in Th1 cells associated with increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1.
Jackson SK; DeLoose A; Gilbert KM
J Immunol; 2001 Jan; 166(2):952-8. PubMed ID: 11145672
[TBL] [Abstract][Full Text] [Related]
16. Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function.
Rowell EA; Walsh MC; Wells AD
J Immunol; 2005 Mar; 174(6):3359-68. PubMed ID: 15749868
[TBL] [Abstract][Full Text] [Related]
17. Differential association of protein tyrosine kinases with the T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation.
Boussiotis VA; Barber DL; Lee BJ; Gribben JG; Freeman GJ; Nadler LM
J Exp Med; 1996 Aug; 184(2):365-76. PubMed ID: 8760790
[TBL] [Abstract][Full Text] [Related]
18. Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression.
De AK; Kodys KM; Pellegrini J; Yeh B; Furse RK; Bankey P; Miller-Graziano CL
Clin Immunol; 2000 Jul; 96(1):52-66. PubMed ID: 10873428
[TBL] [Abstract][Full Text] [Related]
19. Peptide-induced anergy in allergen-specific human Th2 cells results in lack of cytokine production and B cell help for IgE synthesis. Reversal by IL-2, not by IL-4 or IL-13.
Fasler S; Aversa G; Terr A; Thestrup-Pedersen K; de Vries JE; Yssel H
J Immunol; 1995 Nov; 155(9):4199-206. PubMed ID: 7594575
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy.
Li L; Godfrey WR; Porter SB; Ge Y; June CH; Blazar BR; Boussiotis VA
Blood; 2005 Nov; 106(9):3068-73. PubMed ID: 16020508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
